US › Healthcare

Nutriband Inc (NTRB)

US · Healthcare · Biotechnology

$6.22-0.80%

Last close · 2026-10-16

Latest quarter · ended 2026-07-31

Revenue

$437,514

Revenue YoY

-29.7%

Net profit

$-880,561

EPS

$-0.07

Net margin

-201.3%

Key statistics

Market cap

$79.3M

Forward P/E

370.4

P/B

16.78

Book value

$0.44

EPS (TTM)

$-0.53

52-week high

$9.19

52-week low

$2.80

50-day MA

$5.52

200-day MA

$4.25

Beta

1.93

Analyst view

Analysts rate Nutriband Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $15.00.

Shareholding

Insiders

59.09%

Institutions

2.90%

Largest institutional holders

Fund	Stake
Vanguard Capital Management, LLC	1.44%
Geode Capital Management, LLC	0.51%
Vanguard Fiduciary Trust Co	0.21%
State Street Corp	0.21%
Citadel Advisors Llc	0.16%
Northern Trust Corp	0.10%
Haven Private, LLC	0.09%
BlackRock Inc	0.09%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Nutriband Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.